Substantial progress has been made over the past two decades in detecting, predicting and
promoting recovery of consciousness in patients with disorders of consciousness (DoC) …

Aneurysmal subarachnoid hemorrhage (SAH) affects six to nine people per 100,000 per
year, has a 35% mortality, and leaves many with lasting disabilities, often related to cognitive …

Aneurysmal subarachnoid hemorrhage (SAH) is a sub-type of hemorrhagic stroke
associated with the highest rates of mortality and long-term neurological disabilities. Despite …

Background: Delayed cerebral ischemia (DCI) is a common and serious complication of
aneurysmal subarachnoid hemorrhage (aSAH). Though many clinical trials have looked at …

Abstract Interleukin 6 (IL-6) is a prominent proinflammatory cytokine and has been
discussed as a potential biomarker for delayed cerebral ischemia (DCI) following …

Spontaneous subarachnoid hemorrhage (SAH) affects people with a mean age of 55 years.
Although there are about 9/100 000 cases per year worldwide, the young age and high …

Background Long-term continuous intra-arterial nimodipine infusion (CIAN) is a rescue
therapy option in cases of severe refractory cerebral vasospasm (CV) following acute non …

Background Recent surveys have failed to examine cerebrovascular aneurysm treatment
practices among US physicians. Objective To survey physicians who are actively involved in …

Background and Objective To test the hypothesis that age-specific, sex-specific, and race-
specific and ethnicity-specific incidence of nontraumatic subarachnoid hemorrhage (SAH) …

The worldwide incidence of spontaneous subarachnoid hemorrhage is about 6.1 per
100,000 cases per year (Etminan et al., 2019). Eighty-five percent of cases are due to …